RECRUITINGINTERVENTIONAL
Cervical Plexus Hydrodissection With D5W for PTSD
Cervical Plexus Hydrodissection With D5W for PTSD Versus Delayed Treatment/Usual Care
About This Trial
PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.
Who May Be Eligible (Plain English)
Who May Qualify:
- Not involved in another study of PTSD treatment
- Reliable transportation
- Comfortable with computers
- Tried 2 or more medications for treatment of PTSD symptoms
- Tried 2 or more non-medication treatments for PTSD symptom
- No known life-threatening illness
- Not taking daily narcotics
- Not having 3or more alcoholic drinks on an average day
- No active suicidal plans
- No major surgery plans
- No major life stress that might interfere with completing study
- Symptoms for more than 1 year
- Not planning to move for next 18 months.
- Living within an hour of Portlland, OR, Madison, WI, or Lexington, KY
- Wiling to provide 2 email and 2 phone contact methods
- Willing to answer questions on multiple occasions over the course of a year.
- Willing to be assigned to 3 months of usual care treatment
- No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.
- No severe needle phobia
- Chronic pain ≤ 5/10
- PCL-C score ≥ 50
Who Should NOT Join This Trial: None separate from inclusion criteria
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Not involved in another study of PTSD treatment
* Reliable transportation
* Comfortable with computers
* Tried 2 or more medications for treatment of PTSD symptoms
* Tried 2 or more non-medication treatments for PTSD symptom
* No known life-threatening illness
* Not taking daily narcotics
* Not having 3or more alcoholic drinks on an average day
* No active suicidal plans
* No major surgery plans
* No major life stress that might interfere with completing study
* Symptoms for more than 1 year
* Not planning to move for next 18 months.
* Living within an hour of Portlland, OR, Madison, WI, or Lexington, KY
* Wiling to provide 2 email and 2 phone contact methods
* Willing to answer questions on multiple occasions over the course of a year.
* Willing to be assigned to 3 months of usual care treatment
* No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.
* No severe needle phobia
* Chronic pain ≤ 5/10
* PCL-C score ≥ 50
Exclusion Criteria: None separate from inclusion criteria
Treatments Being Tested
PROCEDURE
BCPHD with D5W
D5W is injected under the investing fascia of the sternocleidomastoid muscle (SCM) using ultrasound guidance in order to infiltrate the space containing the cervical plexus. This is performed on both sides.
PROCEDURE
Waiting period with usual care
Same as previous group description
Locations (4)
Danesh Mazloomdoost
Lexington, Kentucky, United States
Paul W. Johnson, D.O., Clinic.
Portland, Oregon, United States
NW Regen
Tigard, Oregon, United States
Eric Phillippi M.D. Clinic
Madison, Wisconsin, United States